Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Science and technology help in simplifying tumour testing

Factor D: Can blocking immune system pathway stop COVID-19?

Tata Medical Center Proteomics Research Assistant Recruitment

Science and technology help in simplifying tumour testing
  • BiotechToday
  • World

Science and technology help in simplifying tumour testing

bioxone October 14, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata

We live in a world that needs more fast methods to be used from day-to-day problems to higher or complicated forms of problems; the healthcare system is not excluded from these. Patients are needing immediate treatment after quick testing which mostly depends on the equipment and the techniques used. This system is known as point-of-care testing (POCT). One of the health issues which need efficient POCT is the detection of the circulating tumour cells (CTCs). Tumour, as we know is complicated and thus the treatment if goes wrong can cause more harm than benefits and the POCT sometimes shows wrong results thus questioning the chemotherapy which the patient is going to opt for and thus putting his life into danger.  

In recent research, Chen Yangfei and his team have come up with a solution to overcome this problem. They have built a device that simplifies the testing processes and guarantees a more accurate result. It is a microscopic CTC cytometer which has a large field-of-view and is also automatic. It being of low weight, less expensive, more accurate, and utilizing LXW7 (a novel peptide) functionalized to magnetic beads for rapid testing can easily replace the previously used techniques and prove to be more selective and sensitive. 

Thus, when the world is changing so much, we too need to change our views and experience science and technology everywhere while promoting it into more application-based and created ways.

Also read: COVID UPDATE: Decrease in daily active cases in India

Source: Yangfei Chen, Xuqi Chen, Meng Li, Pengwei Fan, Bin Wang, Sheng Zhao, Weimin Yu, Shaohua Zhang, Yucheng Tang, Tingjuan Gao. A new analytical platform for potential-of-care testing of circulating tumor cells. (2020). Biosensors and Bioelectronics. DOI:http://10.1016/j.bios.2020.112718

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged chemotherapy CTCs cytometer rapid testing LXW7 (a novel peptide) functionalized to magnetic beads microscopic CTC cytometer POCT rapid tumor testing rapid tumour testing simplifying tumour testing tumor tumour testing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Tata Medical Center Proteomics Research Assistant Recruitment

bioxone October 14, 2020

-Shristi Sharma, Team bioXone Tata Medical Center Vacancies – MSc Biological Sciences Job. Tata Translational Cancer Research Center Recruitment Research Assistant in Proteomics Job Opening. MSc Biological Sciences candidates are encouraged to apply: Application for the position of Research Assistant in Proteomics at TTCRC (Tata Medical Center) Last date of Application: 31/10/2020 The Position Minimum […]

Related Post

  • BiotechToday
  • India

Oxford-AstraZeneca: CDSCO approved after several debates

bioxone January 2, 2021January 2, 2021

Camelia Bhattacharyya, Amity University Kolkata When dealing with treatments relating to human health, we need to take care of two things: i.) the cure should be developed on the basis of all criteria including the majority of the population, and ii.) side-effects should be absent or negligible. Any drug or vaccine to be identified safe, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

You could be at greater COVID risk if you have Neanderthal genes

bioxone October 5, 2020October 5, 2020

-Anuska Sen, Team bioXone Neanderthals also called Homo neanderthalensis or Homo sapiens neanderthalensis are an extinct group of early humans, which was existent almost 40,000 years back. These individuals lived in Eurasia until they became extinct and there are pieces of evidence that till date a certain percentage of Europeans and South Asians are genetically linked to these Neanderthals. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

AstraZeneca Vaccine: Successful Clinical Trial results

BioTech Today August 29, 2021August 29, 2021

Aqsa, Jamia Millia Islamia Vaccination is the quickest and most effective way to protect against infectious diseases. It helps your body to recognize the specific pathogen and generate an immune response against it. Different vaccines have been developed against the causative agent of the current Covid-19 pandemic. These vaccines have undergone successful clinical trials and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy